Skip to content

Comparative Study Between Combined Vaginal Misoprostol

Comparative Study Between Combined Vaginal Misoprostol With Isosorbide-5-Mononitrate Versus Misoprostol Alone For Induction Of The First Trimester Missed Abortion A Randomized Clinical Trial

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04981457
Acronym
comparative
Enrollment
60
Registered
2021-07-29
Start date
2021-03-02
Completion date
2021-10-31
Last updated
2021-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Missed Abortion

Brief summary

Comparative study between Combined Vaginal Misoprostol with Isosorbide-5-Mononitrate

Detailed description

Comparative study between Combined Vaginal Misoprostol with Isosorbide-5-Mononitrate versus Misoprostol Alone For Induction Of The first trimester Missed Abortion A Randomized Clinical Trial

Interventions

DRUGMisoprostol and iso sorbide mononitrates

drug

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

A Randomized Clinical Trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* \- Maternal Age 18 - 35 years. * Gestational age first trimester of pregnancy (between 5-13 weeks). * Missed abortion confirmed by ultrasound. * Singleton pregnancy. * Normal uterus and cervix on clinical examination. * Cervix is not dilated. * No vaginal bleeding.

Exclusion criteria

- Evidences suggesting start of spontaneous abortion and previous trial to induce abortion. * Presence of uterine contraction or bleeding, * Multi-fetal pregnancy. * Suspicion of septic abortion. * History of Previous cervical surgery or manipulation. Ex: cervical tear , cervical cauterization . * Uterine anomaly. * Presence of IUD( intrauterine device) in situ * Underlying medical diseases.Ex:diabetes mellitus,hypertension * History of allergy or adverse effects to vaginally administered medication e.g. isosorbide -5- mononitrate * Those unwilling to participate in the trial * Higher order cesarean section(more than three

Design outcomes

Primary

MeasureTime frameDescription
Induction to abortion interval6 monthsInduction to abortion interval: the Duration interval between the beginning of the induction and beginning of cervical ripening assessed by cervical examination(cervix become soft and start to dilate) and uterine contractions leading to complete expulsion of the abortus spontaneous and if cervical ripening isn't occur by maximum doses the investigators will make surgical evacuation.
Number of the doses6 monthsthe Number of the doses of misoprostol needed to complete expulsion (spontaneous or surgical)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026